PMNs of NASH patients showed a significant increase of cell survival (%Annexin V-/Live Dead-) respect to PMNs of HD and NAFL patients, regardless of the presence of PBMCs (Figure 4(b)). This evidence concerns the gene ANXA5 and metabolic dysfunction-associated steatohepatitis.